Your browser doesn't support javascript.
loading
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease.
Li, Li; Chen, Rirong; Zhang, Yingfan; Zhou, Gaoshi; Chen, Baili; Zeng, Zhirong; Chen, Minhu; Zhang, Shenghong.
Affiliation
  • Li L; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen R; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhang Y; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhou G; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen B; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zeng Z; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen M; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhang S; Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Front Immunol ; 12: 646673, 2021.
Article in En | MEDLINE | ID: mdl-34367126
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Biomarkers / Crohn Disease / Chemokine CCL2 / Matrix Metalloproteinase 3 / Infliximab Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Biomarkers / Crohn Disease / Chemokine CCL2 / Matrix Metalloproteinase 3 / Infliximab Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Suiza